The review, authored by Mohammed F. Hamdi of the University of Al Maarif in Iraq, does not claim that sitagliptin is a proven hazard. Instead, it uses the compound as a sentinel, a model case for stress-testing the dominant tool of pharmaceutical environmental regulation: the comparison of a predicted environmental concentration against a predicted no-effect concentration, known as the PEC/PNEC ratio. When that ratio stays below one, regulators typically conclude the risk is acceptable. The problem, Hamdi argues, is that this calculation is built around the parent compound in surface water, while real-world exposure in water-reuse agroecosystems unfolds in soil, in the presence of organic matter, biosolids, mixtures of other drugs, and a shifting cast of transformation products that the standard framework never accounts for.

The scale of the underlying exposure problem is well documented. Pharmaceuticals are excreted partially unchanged, pass through conventional wastewater treatment with variable efficiency, and enter rivers, groundwater, and irrigation systems worldwide. Global surveys have detected hundreds of active pharmaceutical ingredients in the waterways of every inhabited continent, and reclaimed wastewater is increasingly promoted as a strategic resource in water-stressed regions. The European Union has even adopted minimum requirements for water reuse in agriculture, formalizing a practice that delivers not only water but also trace organic chemicals, including antidiabetic drugs, directly onto cropland.

What makes sitagliptin especially interesting is what happens to it in soil. Direct experimental evidence shows that its retention in soil is strongly matrix-dependent, meaning it varies with soil organic matter content and pH. More strikingly, co-exposure to biosolids, sewage effluent, and metformin, another ubiquitous antidiabetic drug, can reduce sitagliptin sorption under tested conditions. In practical terms, the very amendments farmers apply to enrich their soils, and the very co-contaminants that travel with treated wastewater, may loosen the drug’s grip on soil particles and plausibly increase its mobility. A compound that looks stationary and benign in a simple laboratory sorption test may behave quite differently in a biosolids-amended field receiving effluent-dominated irrigation water.

This mobility question matters because dissolved organic matter, or DOM, acts as a chemical shuttle in soil systems. Organic molecules derived from manure, sludge, and wastewater can bind pharmaceuticals and carry them through soil profiles, a mechanism demonstrated for other drugs such as sulfadiazine, caffeine, and atenolol. Soil column experiments have confirmed that contaminants of emerging concern can move through soil under realistic flow conditions, and studies of riverbed sediments show that pharmaceuticals interact with benthic biofilms and suspended particles in ways that simple water-column models ignore. For a polar, relatively mobile compound like sitagliptin, these facilitation pathways could extend its residence and reach well beyond what a PEC calculated from river concentrations would suggest.

Field-scale studies of reclaimed-water irrigation do support the idea that soils accumulate pharmaceutical residues over time. Research on processing tomato and wheat successions irrigated with treated wastewater has documented accumulation of emerging contaminants in the soil-plant system, and large surveys, notably in Israel where wastewater reuse is extensive, have detected pharmaceuticals in edible crops. Yet the review is careful about what this evidence does and does not show: field studies support soil exposure and accumulation for sitagliptin, but they do not demonstrate edible-crop contamination or food-chain risk for this specific drug. That distinction is crucial. The absence of demonstrated dietary exposure is not proof of safety, but neither is soil accumulation proof of harm, and the review resists both overstatements.

Perhaps the most consequential finding concerns transformation products, the chemical offspring of pharmaceuticals that form during treatment and environmental degradation. Sitagliptin is not destroyed by conventional biological treatment so much as biologically transformed, and advanced processes such as ozonation generate a suite of oxidative transformation products whose identities, kinetics, and pathways have been mapped in laboratory and full-scale studies. Ultraviolet irradiation likewise produces characteristic degradation products. Crucially, attenuation of the parent compound in a treatment plant or a river does not equal risk closure. The transformation products may persist, may be mobile, and may carry toxicity of their own, and in most regulatory assessments they are simply not evaluated. Recent work on hyporheic zones, the ecologically active sediments beneath and beside rivers, adds nuance: sequential anoxic and oxic conditions there can biotransform sitagliptin and reduce its toxicity, suggesting that some natural systems genuinely degrade the drug rather than merely relocating or reshaping it.

The mixture dimension compounds the uncertainty. Wastewater-impacted waters never contain a single drug in isolation; they carry cocktails of antidiabetics, antibiotics, analgesics, and their metabolites, alongside dissolved organic matter that modifies both transport and bioavailability. Environmental risk assessment of pharmaceutical mixtures remains one of the field’s most persistent gaps, with recognized demands for combined-toxicity approaches that current regulatory practice rarely meets. Metformin, the world’s most prescribed diabetes drug and a frequent companion of sitagliptin in effluent, has itself become a poster child for this problem, since its transformation product guanylurea is persistent and widespread yet historically absent from risk calculations. The sitagliptin review explicitly frames mixture uncertainty as a reason why a low PEC/PNEC ratio for one parent compound cannot automatically close the file.

So where does this leave the drug itself? The review’s conclusion is deliberately measured: sitagliptin is not reclassified as a proven high-risk contaminant. Its aquatic risk assessment for the parent compound remains valid within its own terms. What the analysis challenges is the inference that those terms are sufficient. When land application of biosolids, irrigation with reclaimed water, DOM-facilitated transport, co-occurring pharmaceuticals, and incompletely characterized transformation products all reshape exposure, a clean aquatic assessment of the parent molecule says little about what happens in an irrigated field or a hyporheic sediment. The author’s proposal is not alarm but expansion: environmental evaluation should not end at the water’s edge, and low parent-compound risk should not function as a certificate of overall safety.

The broader lesson extends well beyond one diabetes medication. As water reuse expands globally and pharmaceutical consumption rises with aging populations, the chemicals that slip through treatment plants will increasingly land on the soils that grow our food. Sentinel compounds like sitagliptin expose the structural blind spots of a regulatory system designed for a simpler exposure world, and they point toward the next generation of assessment tools: soil-aware fate models, mixture toxicity frameworks, transformation product screening, and monitoring that follows drugs from effluent through root zone to crop. Whether regulators adopt that broader lens may determine whether the quiet accumulation of pharmaceuticals in reused-water agroecosystems remains a scientific curiosity or becomes one of the defining contamination stories of the coming decades.

Subject of Research: Environmental fate and risk assessment of the antidiabetic drug sitagliptin in water-reuse agroecosystems

Article Title: Sitagliptin beyond low aquatic risk: mobility, transformation products, and mixture uncertainty in water-reuse agroecosystems

Article References: Hamdi, M. F. (2026). Sitagliptin beyond low aquatic risk: mobility, transformation products, and mixture uncertainty in water-reuse agroecosystems. Environmental Science and Pollution Research. https://doi.org/10.1007/s11356-026-38297-4

Image Credits: AI Generated

DOI: 10.1007/s11356-026-38297-4

Keywords: sitagliptin, pharmaceutical pollution, reclaimed wastewater, soil sorption, transformation products, biosolids, dissolved organic matter, metformin, crop uptake, hyporheic zone, risk assessment, water reuse

The paradox at the heart of pesticide risk assessment is that a compound’s apparent safety often rests on how quickly it degrades. Metazachlor fits the profile of a well-behaved chemical: it sorbs moderately to soil particles and dissipates rapidly, with measured half-lives of just 7 to 17 days across the soils tested. In theory, a compound that vanishes that quickly poses little threat to aquatic ecosystems. But degradation does not mean destruction. When metazachlor breaks down, it does not simply disappear; it transforms into a family of metabolites, most prominently metazachlor oxanilic acid, known as OA or 479M04, and metazachlor ethanesulfonic acid, known as ESA or 479M08. These transformation products are routinely detected in surface water, groundwater and even drinking water across Europe, from Luxembourg’s main drinking water reservoir to German agricultural streams.

The research team, led by Radka Kodešová of the Czech University of Life Sciences Prague, set out to quantify precisely how metazachlor and its metabolites behave in real soils. Working with eight representative Czech soil types, ranging from fertile Chernozems on loess to a sandy Arenic Regosol, the researchers conducted standardized batch experiments to measure sorption, the process by which chemicals bind to soil particles, and dissipation, the rate at which compounds break down. Sorption matters because strongly bound chemicals stay put; weakly bound ones leach downward with percolating water. The team used the OECD batch equilibrium method, shaking soil samples with calcium chloride solutions containing the compounds at environmentally relevant concentrations, then measuring what remained in the liquid phase using ultra-performance liquid chromatography coupled with tandem mass spectrometry.

The sorption results were stark. Metazachlor’s Freundlich sorption coefficients ranged from 0.235 to 2.94 cubic centimeters per microgram across the eight soils, while the coefficients for OA and ESA were roughly an order of magnitude lower, between 0.083 and 2.84 for OA and just 0.083 to 0.307 for ESA. In practical terms, the metabolites barely cling to soil at all. Every rainfall event that moves water through the soil profile can carry them toward the water table. Statistical analysis showed that sorption of all three compounds correlated positively with soil organic carbon content, as expected from hydrophobic and hydrogen-bonding interactions, but also with sand and silt content and, for the acidic metabolites, with hydrolytic acidity. The negative relationship with clay content suggests that the negatively charged metabolite molecules are actually repelled by negatively charged clay particle surfaces, a mechanism that further enhances their mobility.

The degradation experiments told an even more troubling story. When OA and ESA were applied directly to soil, their half-lives ranged from 27 to 274 days for OA and 74 to 618 days for ESA, in some cases more than ten times longer than the parent compound’s dissipation time. But the picture grew darker still when the researchers tracked what happens during metazachlor’s own transformation. Using a first-order kinetic model fitted to concentration measurements taken over 100 days, they calculated that metabolites formed in situ from the degrading parent compound persisted even longer than when applied directly: half-lives of 18 to 492 days for OA, 110 to 231 days for ESA, 15 to 111 days for 479M09, and 39 to 87 days for 479M11. In several soils, these values exceeded the upper limits of published database values, sometimes by a factor of three or more.

Perhaps the most alarming finding concerned the yields of these metabolites. The combined formation fractions of all four metabolites derived from metazachlor ranged from 60 to 95 percent of the applied parent compound, meaning that most of the herbicide applied to a field ultimately converts into these mobile daughter chemicals. The yield of OA, at 27 to 47 percent, was up to 2.9 times higher than the value of 0.162 recorded in the widely used Pesticide Properties DataBase. More striking was the yield of metabolite 479M09, which the database lists at just 0.053 but which the experiments found at 10 to 25 percent, up to 4.7 times the published figure. This matters because 479M09 and its relative 479M11 are considered potentially carcinogenic, unlike OA and ESA, which regulators classify as toxicologically irrelevant. The database assumption that 479M09 is merely a minor transformation product appears to be wrong; the study found it produced at levels nearly comparable to ESA.

The environmental logic of these numbers is sobering. A metabolite that is produced in large quantities, sorbs only weakly to soil, and persists for months has every opportunity to travel. Once such a compound leaches below the root zone into the vadose zone and eventually the groundwater, conditions change dramatically: microbial activity is far lower, temperatures are cooler, and biodegradation slows to a crawl. The researchers note that while 479M09 degrades faster in topsoil than OA and ESA, it may be considerably more stable once it reaches groundwater, where the microbial communities that break these chemicals down are scarce. This combination of high production yield, high mobility and enhanced subsurface stability makes 479M09 a candidate for groundwater contamination that current regulatory models may substantially underestimate.

The study also yielded practical tools for predicting risk across landscapes. Through multiple linear regression, the team derived equations that estimate sorption coefficients and half-lives from measurable soil properties such as oxidizable organic carbon, clay, silt and sand content, and hydrolytic acidity. Half-lives were generally shorter in soils rich in organic carbon and clay, likely because these soils support larger and more active microbial communities with better access to nutrients and oxygen. Such predictive equations can be mapped onto agricultural regions to identify areas where soils offer the weakest retention and slowest degradation, flagging groundwater vulnerability zones before contamination occurs. The approach mirrors methods the same research group has applied to pharmaceuticals and other micropollutants in Czech agricultural soils.

The broader lesson for pesticide regulation is that evaluating a parent compound in isolation paints a dangerously incomplete picture. Databases such as the Pesticide Properties DataBase and assessments by the European Food Safety Authority contain far less information on metabolites than on parent compounds, and the values they do contain may not reflect the behavior of metabolites formed in situ under real soil conditions. The Czech team’s findings suggest that transformation products deserve the same rigorous experimental scrutiny as the chemicals from which they derive, particularly when those products are both mobile and potentially toxic. As monitoring programs across Europe continue to detect metazachlor metabolites in drinking water sources, this study provides a mechanistic explanation for why: the herbicide’s breakdown products are not fleeting traces but persistent, mobile contaminants produced in unexpectedly large quantities, and they may be traveling toward aquifers faster than anyone has been accounting for.

Subject of Research: Sorption, persistence and formation of the herbicide metazachlor and its metabolites in agricultural soils and implications for groundwater contamination

Article Title: Persistence and mobility of metazachlor and its metabolites in soils: Why transformation products pose a greater groundwater risk

Article References: Kodešová, R., Tomešová, D., Kočárek, M., Fér, M., Klement, A., Nikodem, A., Zelinka, J., & Kodeš, V. (2026). Persistence and mobility of metazachlor and its metabolites in soils: Why transformation products pose a greater groundwater risk. Environmental Geochemistry and Health, 48(14), Article 567. https://doi.org/10.1007/s10653-026-03452-w

Image Credits: AI Generated

DOI: 10.1007/s10653-026-03452-w

Keywords: metazachlor, pesticide metabolites, groundwater contamination, soil sorption, herbicide degradation, transformation products, soil organic carbon, half-life, water quality, environmental geochemistry, leaching, risk assessment